222 results Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types. Contracts & Corona: force majeure and related topics The spread of the coronavirus may have some consequences that affect your ability to perform your obligations under your contracts, or your co-contractors’ ability to perform theirs. We provide some insight on a few pressing questions. Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review. Stibbe advises Aedifica Stibbe has advised Aedifica on the acquisition and lease of a care residence to be constructed in Dordrecht and the acquisitions and leases of recently completed healthcare residences in Harderwijk and Berkel-Enschot (NL). Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health. Het Nederlandse UBO-register: vermoedelijk nog dit voorjaar operationeel Het is de verwachting dat het Nederlandse Ultimate Beneficial Owner (UBO)-register dit voorjaar operationeel zal zijn. Rechtspersonen moeten zelf informatie over hun UBO’s verzamelen, bijhouden en registreren in het UBO-register. Wet zorgplicht kinderarbeid gepubliceerd in het Staatsblad Op 13 november 2019 is de Wet zorgplicht kinderarbeid in het Staatsblad gepubliceerd. Stibbe advises Agendia Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management. Stibbe advises Canon Medical Systems Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon. Stibbe advises former CEO NS On November 21 2017, the Public Prosecutor demanded a year of unconditional prison sentence against the former president Timo Huges of the Dutch Railways (NS) for his role in alleged fraud concerning the tender for regional public transport in Limburg. On Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist). Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group. Stibbe advises on the equity offering of ProQR Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). Stibbe advises SleepScore Labs Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company. Stibbe advises Lundbeck Stibbe advised Lundbeck on the acquisition of Prexton Therapeutics BV for an amount of up to EUR 905 million. Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe. Conference: Erik Valgaeren speaks on Algorithmic Criminal Justice at Computers, Privacy and Data Protection Conference Erik Valgaeren, TMT partner at Stibbe in Brussels, speaks about Algorithmic Criminal Justice at the 14th edition of the annual Computers, Privacy and Data Protection Conference taking place from 27-29 January 2021 in Brussels. Muriël Rosing on panel for GIR Interactive Regional Spotlight The Global Investigations Review is organising the ‘GIR Interactive Regional Spotlight’. During the conference, Muriël Rosing will attend and speak at the panel “The view from continental Europe – key trends impacting compliance and investigations”. Pagination Previous page Page 6 Current page 7 Page 8 Page 9 Next page
Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types.
Contracts & Corona: force majeure and related topics The spread of the coronavirus may have some consequences that affect your ability to perform your obligations under your contracts, or your co-contractors’ ability to perform theirs. We provide some insight on a few pressing questions.
Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review.
Stibbe advises Aedifica Stibbe has advised Aedifica on the acquisition and lease of a care residence to be constructed in Dordrecht and the acquisitions and leases of recently completed healthcare residences in Harderwijk and Berkel-Enschot (NL).
Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health.
Het Nederlandse UBO-register: vermoedelijk nog dit voorjaar operationeel Het is de verwachting dat het Nederlandse Ultimate Beneficial Owner (UBO)-register dit voorjaar operationeel zal zijn. Rechtspersonen moeten zelf informatie over hun UBO’s verzamelen, bijhouden en registreren in het UBO-register.
Wet zorgplicht kinderarbeid gepubliceerd in het Staatsblad Op 13 november 2019 is de Wet zorgplicht kinderarbeid in het Staatsblad gepubliceerd.
Stibbe advises Agendia Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management.
Stibbe advises Canon Medical Systems Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon.
Stibbe advises former CEO NS On November 21 2017, the Public Prosecutor demanded a year of unconditional prison sentence against the former president Timo Huges of the Dutch Railways (NS) for his role in alleged fraud concerning the tender for regional public transport in Limburg. On
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist).
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group.
Stibbe advises on the equity offering of ProQR Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR").
Stibbe advises SleepScore Labs Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company.
Stibbe advises Lundbeck Stibbe advised Lundbeck on the acquisition of Prexton Therapeutics BV for an amount of up to EUR 905 million.
Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.
Conference: Erik Valgaeren speaks on Algorithmic Criminal Justice at Computers, Privacy and Data Protection Conference Erik Valgaeren, TMT partner at Stibbe in Brussels, speaks about Algorithmic Criminal Justice at the 14th edition of the annual Computers, Privacy and Data Protection Conference taking place from 27-29 January 2021 in Brussels.
Muriël Rosing on panel for GIR Interactive Regional Spotlight The Global Investigations Review is organising the ‘GIR Interactive Regional Spotlight’. During the conference, Muriël Rosing will attend and speak at the panel “The view from continental Europe – key trends impacting compliance and investigations”.